Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Uveal Melanoma × tislelizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 8 Esophageal Squamous Cell Carcinoma 6 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Recurrence 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Squamous Cell Carcinoma of Head and Neck 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Multiple Pulmonary Nodules 1 Mid-low Rectal Cancer 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1

Interventions

Ipilimumab 14 incomplete Freund's adjuvant 9 Nivolumab 7 sargramostim 6 montanide ISA 51 5 Temozolomide 5 MART-1 Antigen 5 Dacarbazine 5 Blood Specimen Collection 5 Ranibizumab 4 Melphalan 4 pembrolizumab 3 Surveys and Questionnaires 3 Interleukin-2 3 Carboplatin 3 CTLA-4 Antigen 3 sotrastaurin 2 entinostat 2 aflibercept 2 Thalidomide 2 Taxes 2 Sunitinib 2 Sorafenib 2 Radiosurgery 2 Protein Subunit Vaccines 2 ProMune 2 Paclitaxel 2 MAGEA3 protein, human 2 Interleukin-12 Subunit p35 2 Granulocyte-Macrophage Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05542342 2025-05-14

SITISVEAL

Grupo Español Multidisciplinar de Melanoma

Phase 2 Completed

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡